XML 60 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial results
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Financial results

6. Financial results

 

 

       
    Year ended December 31,
  Notes 2023 2022 2021
Financial income        
Short-term investments   309 440 226
Other   123 80 111
Total financial income    432 520 337
Financial expenses        
Loans and borrowings gross interest 10(c) (744) (612) (671)
Capitalized loans and borrowing costs 10(d) 19 47 59
Interest on REFIS   (148) (152) (54)
Interest on lease liabilities 24 (62) (64) (63)
Bond premium repurchase 10(c) (22) (113) (63)
Interest on accounts payable   (203) (51) (45)
Other   (299) (234) (412)
Total financial expenses    (1,459) (1,179) (1,249)
Other financial items, net        
Foreign exchange and indexation gains (losses), net   (1,643) (975) 132
Participative shareholders' debentures (i) 22 (179) 659 (716)
Financial guarantees (i) 32(b) - 481 312
Derivative financial instruments, net 20 903 1,154 (23)
Reclassification of cumulative translation adjustments to the income statement 15(a) and 16 - 1,608 4,326
Total other financial expenses    (919) 2,927 4,031
Total   (1,946) 2,268 3,119
(i) Items reclassified in comparative to maintain consistency of disclosure.

 

 

Accounting policy

 

Transactions in foreign currencies are translated into the functional currency using the exchange rate effective on the date of the transaction. The foreign exchange gains and losses resulting from the translation at the exchange rates prevailing at the end of the year are recognized in the income statement as “financial income or expense”. The exceptions are transactions related to qualifying net investment hedges, cash flow hedge or items that are attributable to the net investment in a foreign operation, for which gains, and losses are recognized as a component of other comprehensive income.

The accounting policies related to the other items of the financial result are shown in the notes, “15. Investments in associates and joint ventures”, “22. Participative shareholders’ debentures”, “23. Loans, borrowing, cash and cash equivalents and short-term investments” and “24. Leases”.